Overview
Meeting: November 14-15, 2024 | In-Person
The DIA Canada Annual Meeting will deliver a comprehensive overview of the current pharmaceutical, medical device, and/or diagnostic landscapes in Canada, while sharing insights into Canada’s broader role in global healthcare product development and is separated into three tracks: Regulatory, Clinical and Safety and Pharmacovigilance. This meeting will connect attendees with leaders and experts in academia and those involved in the regulatory, clinical, and safety and pharmacovigilance functional areas in the pharmaceutical and medical device industry to explore best practices, lessons learned, and problem-solving strategies effecting stakeholders in Canada.
While we develop our 2024 agenda, please take a moment to review the 2023 final agenda
Need Approval in Order to Attend?
Download and fill out our Justification Letter to demand to supervisor why this is a must-attend event.
Participant Testimonials
What a wonderful event to get up to speed on the latest regulatory and industry developments for drugs and devices, directly from experts and leaders in the field, that includes a number of opportunities to network and get to know speakers and presenters. – Kelly McClellan - Federal Government Canada
Excellent meeting, the presenters from industry and Health Canada were knowledgeable and fully engaged. – Patricia Smith – Otsuka
The quality of the presentations was high and all information discussed was relevant for our job. The ambience was favourable for discussions and great interaction among participants. – Celline Brasil – Health Canada
Program Committee
-
Stephanie Anderson Associate Director, Regulatory Affairs
Intrinsik Corp., Canada -
Rebecca Barnes, MS Executive Director
Network of Networks (N2), Canada -
Vatche Bartekian, MSc President
Vantage BioTrials, Canada -
Katalin Bertenyi Acting Manager, Centre for Blood Products and Biotherapeutics (BRDD)
Health Canada, Canada -
Louise Blythe, MSc VP & Head, Regulatory Affairs
Bayer Inc. Canada, Canada -
Melanie Cote, MS Senior Manager, Regulatory Affairs
Otsuka , Canada -
My Dang, MBA Director/Consultant, Regulatory Affairs
Cencora, Canada -
Zohra Douida, MPharm, MS, MSc Head, Regulatory Affairs Canada
Indivior Canada Inc., Canada -
Tharany Ganesh Head, Regulatory Affairs
AstraZeneca Canada Inc., Canada -
Marie-France Goyer, MSc Director, Clinical Operations
Abcellera, Canada -
Daniel Greco, PharmD, RPh Associate Director of Patient Safety
Bristol-Myers Squibb Company, Canada -
Brenda Gryfe, MSc Director, Regulatory Affairs
TPIreg, Innomar Strategies, Canada -
Oxana Iliach, PhD Senior Director Regulatory Strategy
Certara, Canada -
Nadiya Jirova, MSc Manager, Bureau of Biologics, Radiopharmaceuticals and Self-Care Products
Health Canada, Canada -
Mei Lam, BSN, RN Canada PV Manager/Safety Regional Country Contact
Haleon, Canada -
Randy Levitt, PhD Director, Pharmacovigilance and Medical Affairs
Paladin Labs Inc., Canada -
Amber McLeod, PhD Immunology, Virology, and Specialty Head, Regulatory Affairs
Abbvie Corporation, Canada -
Nadia Mian, MS Pharmacovigilance Manager
Ipsen Biopharmaceuticals Canada Inc., Canada -
Myriam Salem, MSc Pharmacovigilance Manager
Health Canada, Canada -
Marcia Sam Regulatory Affairs Strategy and Policy Manager
Hoffmann-La Roche Canada Limited, Canada -
Vanessa Zapata Associate Director, Regional Pharmacovigilance Officer
Merck Canada Inc., Canada -
Representative Invited DIA, United States
Have an account?